Keros Therapeutics
Develops protein therapeutics for hematological and musculoskeletal disorders.
Company facts
- Founded
- 2015
- Employees
- 82
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: KROS
- Subsidiaries
- Keros Therapeutics Australia Pty Ltd, Keros Security Corporation